CD22 and Alzheimer disease: In addition, TR‐ZRA regulates CD22 levels in cells by delivering CD22 shRNA, which promotes microglial phagocytosis of Aβ, reduces the Aβ burden in cells and AD mice, inhibits microglial neuroinflammation, and facilitates memory capacity in AD mice.